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the presence of HTN (n=217, 52%) if the arterial pressure was >140/90 mm Hg and/or
they were being treated for HTN, and tested serum IgG antibodies to cytomegalovirus,
hepatitis A virus, Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus type
1 and type 2, as well as C-reactive protein (CRP) levels. Results: The prevalence of anti-
bodies to hepatitis A virus or Helicobacter pylori, but not to others, was higher in the HTN
than the non-HTN patients. These associations were significant even after adjustment for
traditional risk factors. Adjusted OR with 95%CL was 1.59 (1.05-2.40) for hepatitis A virus
and 1.75 (1.15-2.68) for Helicobacter pylori infection. In addition, increasing number of
seropositivities (pathogen burden) was significantly associated with increasing HTN risk.
The prevalence of HTN was 58% in the high pathogen burden group (>4 positive antibod-
ies) compared with 45% in the low burden group (P<0.01). The pathogen burden
remained a significant predictor of HTN after multivariate analysis (adjusted OR 1.60 with
95% CL 1.05-2.42). Interestingly, we found that elevated CRP levels (>0.5mg/dL) were
also associated with HTN (adjusted OR 1.80 with 95% CL 1.12-2.87), and that elevated
CRP levels combined with individual infections and pathogen burden increased the risk
of HTN: adjusted OR with 95% CL was 3.09 (1.56-6.12) for hepatitis A virus, 3.68 (1.83-
7.40) for Helicobacter pylori, and 3.15 (1.56-6.37) for pathogen burden. Conclusion: Our
data suggest that infection plays a role in the development of HTN, and elevated CRP
levels can increase the risk posed by infection in HTN.
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1059-11 Venous Endothelium Dysfunction Is Also Presented in 
Hypertensive Patients
Marcelo C. Rubira, Fernanda Marciano Consolim-Colombo, Rodrigo Dm Plentz, Eneida 
Rejane Rabelo, Juan Carlos Yugar-Toledo, Heitor Moreno Junior, Eduardo Moacir 
Krieger, Maria Claudia Irigoyen, Heart Institute, University of São Paulo, Medical School, 
Brazil, São Paulo, Brazil, Federal University of São Paulo, Brazil, São Paulo, Brazil
Background: Endothelium dysfunction has been demonstrated in the arteries of hyper-
tensive patients. Although veins and arteries produce nitric oxide, it is unknown if the
formers are also impaired in the arterial hypertension. The aims of this study were: 1) To
evaluate whether or not the hypertensive patients exhibit venous endothelium dysfunc-
tion; 2) To determine the relationship between endothelium dependent and independent
vasodilation responses in venous and arterial systems in these subjects.
Methods: Sixteen patients with mild hypertension (SBP 145.8 +/- 8.8 mm Hg and DBP
98.3 +/- 4.8 mm Hg), out of medication and without other risk factor, and fifteen matched
normotensive volunteers had the venous and arterial endothelial function evaluated,
respectively, by the dorsal hand vein (DHV) and high resolution ultrasound (flow medi-
ated dilation - FMD) techniques.
Results: The maximal dilation response (Emax), produced by acetylcholine (ACH) was
consistently reproducible, allowing evaluating the venous endothelium dependent
response. Hypertensive group had a marked reduction of Emax to ACh (54,9+/-10,8%)
when compared to normotensive controls (Emax= was 85,2+/-27,0%). The flow mediated
dilation responses were reduced in the hypertensive subjects compared to their controls
(6.6+/1.3 versus 12.4+/-1.4 %, respectively). The responses to nitric oxide donors were
similar in both groups tested by the DHV and FMD methods. By the analysis of the mea-
surement method comparison data (Bland & Altman), the responses both techniques
agreed in normotensive and hypertensive subjects.
Conclusion: Hypertensive patients had an attenuated endothelial-dependent response,
indicating that the endothelium dysfunction observed in arteries is also present in the
venous system.
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1059-12 Sustained Upregulation of Inflammatory Cytokine and 
Its Receptor Genes Associated With Proteinase 
Activation in Abdominal Aortic Aneurysm: Results 
From Combined Study With cDNA Array and Real-Time 
Reverse Transcriptase Polymerase Chain Reaction 
Methods
Takeo Higashikata, Masakazu Yamagishi, Hiroaki Sasaki, Kenji Minatoya, Hitoshi Ogino, 
Hatsue Ishibashi-Ueda, Aiji Sakamoto, Hitonobu Tomoike, National Cardiovascular 
Center Research Institute, Suita, Japan
Background: In the development of aortic aneurym, inflammatory process plays a piv-
otal role in the vessel tissue degradation. Under these conditions, cytokines are known to
serve as an essential mediator of inflammation, contributing to degenerating local tissue
associated with or without aneurysm formation probably through the activation of protein-
ases. However, few data exist regarding which cytokines are important for proteinase
activation associated aneurysm formation. Therefore, we analyzed gene expression lev-
els of cytokines, their receptors and proteinases such as matrix metalloproteinase
(MMPs) in abdominal aortic aneurysm (AAA) by cDNA array and real-time RT-PCR meth-
ods.
Methods and Results: Aortic samples from the maximally dilated and non-dilated (con-
trol) regions were obtained from 22 patients with graft replacement surgery for AAA. The
32P-labeled cDNA probe mixture synthesized from 5 microgram total RNA with gene-
specific primers was hybridized with 388 cytokine-related cDNA array. For 4 pairs of AAA
and control, the signal intensities for each target cDNA normalized to GAPDH were com-
pared. Overt upregulation in AAA was observed for Interleukin (IL)-8 and its receptor
such as CXCR-2, which were further confirmed by real-time RT-PCR method. We also
determine gene expression level of MMP-1, 3, and 9. The expression levels for the IL-8
and CXCR-2 genes were significantly upregulated in AAA compared with control as fol-
lowed: IL-8, 0.53 ± 0.16 Versus 0.11 ± 0.04 (p<0.01); CXCR-2, 2.04 ± 0.75 Versus 0.29 ±
0.10 (p<0.01). Under these conditions, there was significant upregulation of MMP-1 (4.48
± 2.01 Versus 0.26 ± 0.12, p<0.01) and MMP-3 (5.01 ± 0.97 Versus 1.89 ± 1.00, p<0.05)
genes.
Conclusion: Sustained upregulation of IL-8, a CXC-chemokine, and its receptor, CXCR-
2, was observed in the AAA associated with overexpression of MMPs, suggesting that
inflammatory process with proteinase activation contributes to the development of AAA.
This pathway may be an alternative gene or drug target for the treatment of AAA.
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1059-13 Detection and Propagation of Calcified Nanostructures 
From Human Aneurysms
John C. Lieske, Vivek Kumar, Gerard Farell-Baril, Shihui Yu, Jon E. Charlesworth, Ewa 
Rzewuska-Lech, Peter LaBreche, Sandra R. Severson, Virginia M. Miller, Mayo Clinic 
Rochester, Rochester, MN
Background: Mechanisms leading to vascular calcification remain incompletely under-
stood. Nanometer-sized, mineralized structures recognized by a commercially available
monoclonal antibody (8D10, Nanobac OY) are present in calcified human aneurysms.
These structures were not detected by TUNEL staining, suggesting they were not apop-
totic bodies. The 8D10 antibody is directed against nanobacteria, a controversial, slow-
growing, and calcifying microorganism. Therefore, experiments were designed to deter-
mine whether structures from aneurysms are viable, nano-sized organisms.
Methods: Aneurysms (n=3) collected as surgical waste were decalcified, sterile filtered
(0.22 µm), and cultured in DMEM containing gamma-irradiated calf serum.
Results: In 2 of 3 cultures micron-sized particles visible by light microscopy increased in
number over 4-6 weeks. The negative culture came from an aneurysm without stainable
nanoparticles. With transmission electron microscopy (EM), cultured particles showed an
inner core surrounded by a shell of calcium phosphate (documented via energy disper-
sive microanalysis). After dissolution of the shell with EDTA, spherical structures of 50-
100 nm were seen by scanning EM. These cultured particles incorporated [3H]uridine at
a rate 2.3 times greater than control cultures of DMEM containing serum and inorganic
hydroxyapatite (HA) crystals (P<0.01). Therefore, these nanostructures appear to syn-
thesize RNA. Particles cultured from aneurysms also stained with the 8D10 antibody, and
SDS-PAGE of extracted proteins revealed multiple distinct bands, including one (Mr 47
kDa) recognized by the 8D10 antibody. The pattern of proteins extracted from inorganic
HA crystals incubated with DMEM and calf serum did not contain the 47-kDa band rec-
ognized by the 8D10 antibody.
Conclusion: In conclusion, these results suggest that viable nano-sized organisms are
present within calcified human arterial tissue. A cause and effect relationship between
the presence of these organisms and development of arterial calcification remains to be
determined.
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1059-14 C825T Polymorphism of the G-Protein Beta(3) Subunit 
Gene and Atrial Fibrillation: Association of the TT 
Genotype With a Reduced Risk for Atrial Fibrillation
Juergen Schreieck, Stefan Dostal, Nicolas von Beckerath, Annette Wacker, Michelle 
Flory, Sonja Weyerbrock, Sebastian Schmieder, Werner Koch, Claus Schmitt, Deutsches 
Herzzentrum München and 1. Med. Klinik, TU München, Munich, Germany
Background: A polymorphism consisting of a C825T substitution in the G-protein beta(3)
subunit gene (GNB3) has been associated with enhanced signal transduction via het-
erotrimeric G-proteins. Furthermore, association between enhanced human atrial inward
rectifier potassium currents and the TT genotype, but not the CT genotype has been
shown. Therefore, we investigated a possible impact of the GNB3 C825T polymorphism
on atrial fibrillation by genotyping patients with atrial fibrillation and a control cohort of
patients without atrial tachyarrhythmias. Methods: 291 consecutive patients admitted to
our center with symptomatic paroxysmal or persistent AF (mean age 58±10 years) and
292 control patients (59±11 years) were genotyped for the C825T polymorphism.
Patients with coronary heart disease, valvular heart disease or cardiomyopathy were
excluded from the study in order to avoid the influence of disease-related atrial remodel-
ing. Control subjects were 292 consecutive patients admitted to our center in which coro-
nary artery disease was excluded by coronary angiography. The control group had a
similar incidence of cardiovascular risk factors (hypertension, hypercholesterolemia,
body mass index) as the group with atrial fibrillation. Results: The prevalence of the
GNB3 TT genotype was significantly lower in patients with atrial fibrillation (5.8%) than in
the control group (12.0%); however, no significant differences in the frequencies of the
CT and CC genotypes were found. TT genotype was associated with a 51% decrease in
the unadjusted risk (OR: 0.49, 95% CI=0.28-0.85, P=0.01) and a 54% decrease in the
adjusted risk (OR from a multivariant model: 0.46, 95% CI=0.24-0.87, P=0.02) for the
occurrence of atrial fibrillation. Sinus cycle length, P wave duration, PQ interval and rate-
corrected QT interval (QTc) during sinus rhythm were not influenced by the genotype.
Conclusion: The present study suggests an association between the GNB3 TT genotype
and a reduced risk for the occurrence of atrial fibrillation.
Noon
1059-15 Early Administration of Clopidogrel Is Safe After Off- 
Pump Coronary Artery Bypass Surgery
Michael E. Halkos, William A. Cooper, Rebecca Petersen, Omar M. Lattouf, John D. 
Puskas, Joseph M. Craver, Robert A. Guyton, Emory University School of Medicine, 
Atlanta, GA
Background: Patients who undergo off-pump coronary artery bypass (OPCAB) may be
hypercoagulable with an increased risk of early graft thrombosis due to the lack of plate-
let dysfunction that accompanies “on-pump” coronary artery bypass. Clopidogrel, a
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platelet aggregation inhibitor, is indicated in high risk cardiovascular patients to prevent
recurrent ischemic events. Therefore, the purpose of this study was to determine the
safety and efficacy of clopidogrel administration initiated in the early postoperative period
after OPCAB.
Methods: 30-day follow-up of 364 OPCAB patients from Jan-June, 2001 was determined
from prospectively collected data. 193 patients received clopidogrel approximately 4
hours postoperatively if chest tube output < 100cc/hr for 4 hours and then daily for 4-6
weeks. Telephone follow-up was made 6 – 12 months after OPCAB in 93% of clopidogrel
and 88% of non-clopidogrel patients. Adverse cardiovascular events were defined as
unstable angina, myocardial infarction, transient ischemic attack, or stroke.
Results: The 193 clopidogrel patients had significantly higher preoperative risk scores
compared to the 171 non-clopidogrel patients: 3-vessel CAD, 62% vs. 50%, prior PTCA,
26% vs. 16%, prior intracoronary stent placement 19% vs. 7%, and CCS angina III-IV,
58% vs. 37%, p<0.02. None of the clopidogrel patients required reoperation for mediasti-
nal hemorrhage. No group differences in mortality were observed at 6 months. For all risk
categories, no differences in adverse cardiovascular events were observed, 3.4% of clo-
pidogrel patients vs. 5.3% for non-clopidogrel patients, p=NS. However, in low risk
patients (CCS angina score <2 and 1-2 vessel CAD), fewer adverse cardiovascular
events occurred in the clopidogrel group, 1/92 (1.1%) vs. 6/73 (8.2%), p=0.045. Gas-
trointestinal bleeding occurred in 2.2% clopidogrel patients vs. 0.7% non-clopidogrel
patients, p=NS.
Conclusions: According to this protocol, OPCAB patients can safely receive clopidogrel
in the early postoperative period without increased risk for mediastinal hemorrhage. Early
clopidogrel administration after OPCAB may be associated with a reduction in short-term
adverse cardiovascular events.
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1059-16 Can Autologous Myoblast Transplantation Decrease 
Chronic Ischemic Mitral Regurgitation?
Emmanuel Messas, Alain Bel, Miguel Cortes Morichetti, Claire Carrion, Mark 
Handschumacher, Jean-Thomas Vilquin, Michel Desnos, Patrick Bruneval, Philippe 
Menasché, Alain Carpentier, Robert A. Levine, Albert A. Hagege, INSERM, Paris, 
France, Massachusetts General Hospital, Harvard Medical School, Boston, MA
Background: Extensive work has confirmed the relationship between ischemic mitral
regurgitation (MR) and remodeling of the infarcted left ventricle (LV), which displaces api-
cally the papillary muscles to which the mitral leaflets are anchored. This study was thus
designed to assess whether transplantation (Tx) of skeletal myoblasts could reduce
mitral leaflet tethering and chronic ischemic MR by decreasing endsystolic volumes
(ESV) and reshaping the infarcted wall. Methods: An open-chest infero-basal infarction
was created in 14 sheep, thereby resulting in a MR which progressively developed over
the ensuing 8 weeks. At this time point, sheep were randomly allocated to receive previ-
ously expanded autologous skeletal myoblasts (230 million cells, of which 65% were
myoblasts identified by a positive staining for CD56, n = 7) or to serve as controls receiv-
ing culture medium only (n = 7). All injections were made in multiple sites in the infarcted
posterior bulging wall. 3D echocardiography was used for serial evaluations performed
immediately after infarction, 2 months therafter (preTx) and 2 additional months after Tx.
End points included blinded measurements of the tethering distance between the
ischemic medial papillary muscle tip and the anterior annulus, LV ejection fraction and
stroke volume while 2D echo was used for assessing wall motion score (WMS). Results:
Parameters (mean ± SEM) were similar at baseline and at 2 months between the 2
groups. Two months after Tx (i.e., 4 months post infarction), myoblast Tx was found to
have reduced the progression of ischemic MR (regurgitation volume: 0.7 ± 0.5 vs. 5.7 ±
0.9 mL in controls, p < 0.01), the increase in ESV (30.4 ± 1.2 mL vs. 42.0 ± 2.8 mL in
controls, p < 0.01) and the tethering distance (0.01 ± 0.05 cm vs. 0.44 ± 0.12 cm in con-
trols, p = 0.01). The benefits of myoblast Tx were also evidenced by a lesser decrease of
LV ejection fraction (2.9 ± 1.8% vs. 7.8 ± 1.9% in controls, p < 0.01) and a significant
improvement of the WMS (-0.6 ± 0.03 vs. 0.1 ± 0.01, respectively, p < 0.01). Conclusion:
Tx of skeletal myoblasts may attenuate mild to moderate chronic ischemic MR by
decreasing ESV and reshaping the infarcted LV wall, thereby enhancing valve coaptation.
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1059-17 Prolongation of Atrial Effective Refractory Period by 
Biatrial Subthreshold Stimulation
Joseph Y. Chan, Jeffery W.H. Fung, Hamish C.K. Chan, Cheuk Man Yu, John E. 
Sanderson, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, 
Hong Kong
Timely subthreshold atrial extrastimuli (AE) delivered in the refractory period can prevent
the induction of atrial fibrillation (AF) by another AE delivered in the vulnerable period.
This study aims to investigate the effect of subthreshold stimulation (SS) on atrial effec-
tive refractory period (AERP).
Methods: 14 patients without history of AF (9 male and 5 female, mean age of 51) were
recruited. AERP of right atrial septum was determined after 5 minutes of pacing with 4
different protocols and 3 sets of cycle length (CL) commenced in random order with 10
minutes of washout time between each protocol. Protocols were as shown in table below,
pacing at high right atrium (HRA) and bi-atrial (HRA + coronary sinus) was at twice dias-
tolic threshold. SS was commenced by introduction of an electrical impulse of 2.0msec in
duration and 20mA in amplitude at 50msec after the preceding captured pacing impulse.
The mean of 3 AERP measurements was recorded.
Results: Analysis showed that the pacing protocol but not the CL had significant effect
on AERP. Multiple comparisons showed that the Bi-atrial + SS group had significant
longer AERP than all other groups (protocol 4 versus protocol 1, p< 0.001; versus proto-
col 2, p< 0.021; versus protocol 3, p< 0.002) 
Conclusion: Bi-atrial SS significantly prolonged AERP. It is plausible that because SS is 
relatively localized, the larger the area of atrium receives SS the greater its effect on 
AERP. The study result suggests that bi-atrial SS may be an effective therapy for preven-
tion of AF.
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1059-18 The Role of Slow Delayed Rectifier Potassium Current 
(IKs) in Cardiac Electrophysiology and Atrial Fibrillation
Hideko Nakashima, Uwe Gerlach, Stanley Nattel, Montreal Heart Institute, Montreal, PQ, 
Canada, Aventis Pharma, Frankfurt, Germany
Background: The role of IKs in cardiac electrophysiology has been controversial: direct
experimental analysis has been limited by a lack of adequate probes. In this study, we
used a highly-selective IKs blocker, HMR1556 (HMR), to evaluate the IKs contribution to
cardiac electrophysiological function and AF maintenance.
Methods: Anesthetized open-chest dogs were studied before and after HMR alone (1
mg/kg IV), HMR plus nadolol 0.5 mg/kg IV, dofetilide alone (D, 0.16 mg/kg IV) or HMR
plus D (H/D).
Results: HMR alone increased atrial (AERP at cycle length, CL, 300 ms, AERP300:
88±11, M±SD, to 105±13 ms, *p<.05) and ventricular (VERP600: 154±14 to 190±32 ms*)
effective refractory period with positive or no frequency-dependence, and increased
sinus node recovery time (SNRT). Beta blockade eliminated HMR effects on AERP
(AERP300: 99±5 to 101±17 ms) and SNRT, but did not alter changes in VERP (VERP600:
177±19 to 211±11 ms*). D prolonged both AERP (AERP300: 92±4 to 143±17 ms*) and
VERP (VERP600: 179±18 to 213±29 ms*) with reverse use dependence. In the presence
of D, HMR effects were significantly increased, e.g. HMR increased AERP300 22±10% vs
control, H/D increased AERP300 29±12%* vs D; HMR increased VERP600 24±19% vs
control, H/D increased VERP600 32±5%* vs D. In addition, Wenckebach CL was not
affected by HMR alone, but was greatly increased by H/D vs D alone. HMR shortened
the duration of induced vagotonic AF (DAF, 1077±198 to 471±339 sec*), an effect abol-
ished by β-blockade. D had no significant effect on DAF (916±216 to 732±243 ms), but H/
D markedly decreased DAF (to 77±73 ms, p<.001).
Conclusions: IKs plays a role in baseline atrial, ventricular and SA node repolarization in
vivo, with atrial and SA nodal effects being dependent on background β-adrenoceptor
stimulation. IKs also plays a role in AF maintenance in the presence of intact sympathetic
tone. IKs effects are particularly important in the presence of reduced repolarization
reserve, as indicated by the synergistic interaction between HMR and D. This constitutes
the first evaluation of the role of IKs for in vivo cardiac electrophysiology and highlights the
distinct profile of IKs vs IKr blockade.
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1059-19 Effect of Cardiac Resynchronization Therapy in Patients 
With Right Bundle Branch Block
Leslie A. Saxon, Elyse Foster, Teresa De Marco, Jill Schafer, For the CONTAK CD 
Investigators, Keck School of Medicine USC, Los Angeles, CA, UCSF, San Francisco, CA
Background: Cardiac resynchronization therapy (CRT) is indicated for pts with heart fail-
ure and QRS delay. There is no published data evaluating CRT in pts with right bundle
branch block (RBBB). Methods: Data was analyzed at baseline and 6 months in the 501
pts with NYHA FC II-IV heart failure and ICD indications enrolled in the CONTAK CD Trial
(Guidant, Corp). Results: A total of 66/501 (13%) pts had RBBB, 271/501 (62%) had
LBBB and 164/501 (38%) had IVCD. There were no differences in baseline characteris-
tics between RBBB and non-RBBB pts. Unlike non-RBBB pts, RBBB pts did not demon-
strate improvement in symptom status, heart size or LVEF (Table). NYHA FC did not
improve with RBBB pts and the subset of enrolled pts with FC III-IV symptoms also
showed no benefit. Conclusion: CRT may not benefit RBBB pts. A meta-analysis of the
completed controlled trials of RBBB pts is needed to corroborate these findings. Alterna-
tive stimulation sites should be tested in this subset.
AERP±SD(msec)/
CL(msec)
HRA HRA + SS Bi-atrial Bi-atrial +SS
600 218.2 ± 20.0 221.8 ± 20.8 216.8 ± 20.7 242.1 ± 31.8
500 218.6 ± 20.0 224.3 ± 22.2 220.0 ± 24.5 237.9 ± 30.7
400 211.1 ± 24.0 226.8 ± 20.0 225.4 ± 25.5 240.0 ± 32.3
Table
Endpoint Time RBBB CRT/No
CRT, p
Non RBBB CRT/No
CRT, p
V02
(ml/kg/min)
Baseline
6 mo change
13±.5/13±.5
-1±.6/-.1±.6, ns
14±.2/14±.2
1±.3/0±.3, .009
6 min walk (m) Baseline
6 mo change
302±14/302±13
10±18/21±17, ns
320±6/320±6
39±8/13±8, .02
LVIDs (sys/mm) Baseline
6 mo change
54±1/54±1
-1±2/-2±2, ns
59±.5/59±.5
59±.5/59±.5
-4±.7/-.6±.7, < .001
LVEF (%) Baseline
6 mo change
31±1/31±1
2±2/4±1, ns
27±.4/27±.4
6±.8/3±.8, .008
